SCHEMBL4351092

SCHEMBL4351092

Cc1ccccc1CNC(=O)N(S)c1cc(Cl)ccc1O

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
SCN10A Q9Y5Y9 2/20 0.44
SCN2A Q99250 1/20 0.44
KCNMA1 Q12791 1/20 0.43
KMT2A Q03164 3/20 0.43
GAA P10253 2/20 0.43
ALDH1A1 P00352 4/20 0.43
HPGD P15428 3/20 0.43
ANO1 Q5XXA6 1/20 0.42
ANO2 Q9NQ90 1/20 0.42
MEN1 O00255 2/20 0.41
LMNA P02545 1/20 0.41
HTT P42858 1/20 0.40
KDM4E B2RXH2 1/20 0.40
PPARG P37231 1/20 0.39
CA2 P00918 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4347022 0.85 NPC1 (0.45) NPC1RAB9ASCN10ASCN2AKMT2A
SCHEMBL4357813 0.81 HSD17B2 (0.44) NPC1RAB9ASCN10ASCN2AKMT2A
SCHEMBL4349821 0.81 KMT2A (0.48) NPC1RAB9AKMT2AGAAALDH1A1
SCHEMBL4347982 0.80 NPC1 (0.41) NPC1RAB9ASCN10ASCN2AKMT2A
SCHEMBL4351422 0.80 NPC1 (0.44) NPC1RAB9AKMT2AGAAALDH1A1
SCHEMBL4350885 0.79 NPC1 (0.42) NPC1RAB9ASCN10ASCN2AKMT2A
SCHEMBL4348825 0.78 NPC1 (0.45) NPC1RAB9ASCN10ASCN2AKMT2A
SCHEMBL4349848 0.77 KMT2A (0.44) NPC1RAB9AKMT2AGAAALDH1A1
SCHEMBL4349972 0.77 RAB9A (0.66) NPC1RAB9ASCN10ASCN2AKCNMA1
SCHEMBL4358620 0.76 HPGD (0.43) NPC1RAB9AKMT2AGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP claimed
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors JERINI AG (DE) 2007-03-08 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF NR1I3, NR1D1, NR1D2 NPC1 815/4885RAB9A 4228/4885SCN10A 727/4885
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors NR1I3, NR1D1, NR1D2 NPC1 1189/4885RAB9A 4588/4885SCN10A 1450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.